Cannagistics Inc. (CNGT) financial statements (2022 and earlier)

Company profile

Business Address 150 MOTOR PARKWAY
HAUPPAUGE, NY 11788
State of Incorp. DE
Fiscal Year End July 31
SIC 2833 - Medicinal Chemicals and Botanical Products (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

1/31/2022
TTM
7/31/2021
7/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1301
Cash and cash equivalents1301
Prepaid expense2515 
Other undisclosed current assets33 23
Total current assets:584524
Noncurrent Assets
Finance lease, right-of-use asset  31
Operating lease, right-of-use asset  23
Other undisclosed noncurrent assets  (19)
Total noncurrent assets:  35
TOTAL ASSETS:584559
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:1,2781,059583
Other undisclosed accounts payable and accrued liabilities1,2781,059583
Debt5203,1922,645
Due to related parties494416388
Other undisclosed current liabilities4,0711,025200
Total current liabilities:6,3635,6923,817
Noncurrent Liabilities
Long-term debt and lease obligation  39
Finance lease, liability  39
Total noncurrent liabilities:  39
Other undisclosed liabilities  865
Total liabilities:6,3635,6924,720
Stockholders' equity
Stockholders' equity attributable to parent(6,305)(6,232)(4,661)
Preferred stock  10
Common stock266190105
Treasury stock, value(45)(45)(45)
Common stock, share subscribed but unissued, subscriptions receivable(290)(290) 
Additional paid in capital25,21224,4868,491
Accumulated deficit(32,034)(30,572)(13,222)
Other undisclosed stockholders' equity attributable to parent585  
Other undisclosed stockholders' equity 585 
Total stockholders' equity:(6,305)(5,647)(4,661)
TOTAL LIABILITIES AND EQUITY:584559

Income statement (P&L) ($ in thousands)

1/31/2022
TTM
7/31/2021
7/31/2020
Revenues2,8971,482 
Gain (loss) on disposition of assets for financial service operations2,7661,482(56)
Gross profit:2,8971,482 
Operating expenses(1,423)(647)(1,696)
Other undisclosed operating income (loss)(2,766)(1,482)56
Operating loss:(1,423)(647)(1,696)
Nonoperating income18,94216,703556
Interest and debt expense(1,371)(761)(465)
Net income (loss):16,14815,296(1,605)
Other undisclosed net loss attributable to parent(33,986)(32,646)(1,078)
Net loss available to common stockholders, diluted:(17,837)(17,350)(2,683)

Comprehensive Income ($ in thousands)

1/31/2022
TTM
7/31/2021
7/31/2020
Net income (loss):16,14815,296(1,605)
Comprehensive income (loss), net of tax, attributable to parent:16,14815,296(1,605)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: